Vyriad

0 followers

‌

Vyriad is developing the next generation of targeted cancer therapies using engineered viruses that selectively attack cancer cells and ignite robust immune responses to prevent cancer recurrence.

Industries

Biotechnology

Headquarters

Rochester, United States

Employees

51-200

Links

Org chart

Stephen J. Russell

Co-Founder & CEO

Stephen J. Russell

Collapse

CTO

CFO

Director of Legal

Supply Chain Manager

Human Resources Manager

Sheri Tran

Sr Director of Quality and Compliance

Heather Bakalyar

Senior Director Of Intellectual Property

Luke Russell, Ph.D

Director, Business Development and Strategic Alliances

Alice S. Bexon

Chief Medical Officer

Teams

Business Operations

5 members

Research and Development

5 members

Leadership Team

4 members

Quality Assurance and Compliance

3 members

Similar companies

Halozyme Therapeutics

5 followers

REVOLUTION Medicines

5 followers

Kymera Therapeutics

5 followers

C4 Therapeutics

4 followers

Stemline Therapeutics

3 followers

Inari

3 followers

Prelude Therapeutics

3 followers

Active Motif

3 followers

Pivot Bio

2 followers

Vor Biopharma

2 followers

Generation Bio

2 followers

Explore companies